Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001753926-25-000391
Filing Date
2025-03-03
Accepted
2025-03-03 17:24:22
Documents
2
Period of Report
2025-02-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1589
2 POWER OF ATTORNEY g084723_ex24.htm EX-24 16558
  Complete submission text file 0001753926-25-000391.txt   19720
Mailing Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866
Business Address 179 RTE 46W, SUITE 15 #147 ROCKAWAY NJ 07866 929-459-4966
Innovation1 Biotech Inc. (Issuer) CIK: 0001629205 (see all company filings)

EIN.: 822275255 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 169 MADISON AVE., #15129 NEW YORK NY 10016
Business Address
Knipper Samuel J (Reporting) CIK: 0002057523 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55852 | Film No.: 25699717